tiprankstipranks
Trending News
More News >
PTC Therapeutics (PTCT)
NASDAQ:PTCT
US Market

PTC Therapeutics (PTCT) Income Statement

Compare
407 Followers

PTC Therapeutics Income Statement

Last quarter (Q4 2025), PTC Therapeutics's total revenue was $164.68M, a decrease of -22.75% from the same quarter last year. In Q4, PTC Therapeutics's net income was $-134.97M. See PTC Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.73B$ 806.78M$ 937.82M$ 698.80M$ 538.59M
Gross Profit
$ 1.66B$ 749.38M$ 872.34M$ 654.12M$ 506.26M
Operating Expenses
$ 802.39M$ 1.05B$ 1.31B$ 1.10B$ 880.71M
Depreciation and Amortization
$ 38.81M$ 75.66M$ 236.59M$ 128.84M$ 64.13M
EBITDA
$ 887.66M$ -120.46M$ -330.34M$ -367.78M$ -368.18M
Operating Income
$ 856.51M$ -302.57M$ -439.50M$ -447.41M$ -374.44M
Other Income/Expenses
$ -159.89M$ -60.55M$ -256.61M$ -140.08M$ -143.90M
Pretax Income
$ 696.62M$ -363.12M$ -696.11M$ -587.49M$ -518.34M
Net Income
$ 682.64M$ -363.30M$ -626.60M$ -559.02M$ -523.90M
Per Share Metrics
Basic EPS
$ 8.58$ -4.73$ -8.37$ -7.79$ -7.43
Diluted EPS
$ 7.78$ -4.73$ -8.37$ -7.79$ -7.43
Weighted Average Shares Outstanding
79.53M 76.85M 74.84M 71.73M 70.47M
Weighted Average Shares Outstanding (Diluted)
88.31M 76.85M 74.84M 71.73M 70.47M
Currency in USD

PTC Therapeutics Earnings and Revenue History